drugset / Trial / NCT01972776
A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076.
RandomizedParallel-groupTriple-blindBasic science
Summary
This was a 2 Part study. Part 1 was a safety and tolerability study in GOLD I-III COPD patients. Part 2 was an efficacy study in GOLD I-III COPD patients.
Timeline
- Start
- 2013-11
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | QBM076 | Unknown | 25 mg | — |
| Subject | QBM076 | Unknown | 75 mg | — |
| Subject | QBM076 | Unknown | 150 mg | — |